Ischemic Stroke Clinical Trial
Official title:
Neuromuscular Electrical Stimulation in Acute Ischemic Stroke
The purpose of the study is to examine the added effect of NeuroMuscular Electric Stimulation
(NMES) in addition to exercise therapy in the acute phase of ischemic stroke.
This randomized controlled trial includes 50 patients allocated to either control or
intervention.
The inclusion, test, training and re-test will be provided during the first 14 days after
ictus, starting day 1 or 2 after ictus and a follow-up at day 90.
The exercise training with external NMES is done with the patient every weekday for 12
minutes.
Stroke is the third most cause of disability in adults over 65 years of age worldwide. In
2008, 30.7 million people had survived a stroke. Every year, there are about 14,000 new cases
of stroke in Denmark and the number is expected to rise with about 40% by 2035, due to the
increasing population of elderly. Stroke survivors have the worst odds of reporting severe
disability and the greatest variety of individual domains of disability compared to a range
of other diseases. Therefore, these patients have essential rehabilitation needs. Little is
known about who will benefit from functional interventional rehabilitation and what kind of
intervention is best.
The purpose of the study is to examine the added effect of NeuroMuscular Electric Stimulation
(NMES) in addition to exercise therapy in the acute phase of ischemic stroke.
This RCT includes 50 patients allocated to either control or intervention. The inclusion,
test, training and re-test will be provided during the first 14 days after ictus, starting
day 1 after ictus and a follow-up at day 90.
The exercise training with external NMES is done with the patient every weekday for 12
minutes.
If NMES increases functionality in acute stroke patients it would mean a greater degree of
independence for individual patients and thus have the potential to improve on a major
problem for society.
By combining comorbidity, stroke severity, and other demographic data it might be possible to
get a greater knowledge about who will benefit from the intervention and early rehabilitation
and that will be the a step towards "personalized medicine" in stroke rehabilitation.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05196659 -
Collaborative Quality Improvement (C-QIP) Study
|
N/A | |
| Recruiting |
NCT06027788 -
CTSN Embolic Protection Trial
|
N/A | |
| Completed |
NCT03281590 -
Stroke and Cerebrovascular Diseases Registry
|
||
| Recruiting |
NCT05518305 -
Platelet Expression of FcγRIIa and Arterial Hemodynamics to Predict Recurrent Stroke in Intracranial Atherosclerosis
|
||
| Recruiting |
NCT06029959 -
Stroke and CPAP Outcome Study 3
|
N/A | |
| Recruiting |
NCT03728738 -
Zero Degree Head Positioning in Hyperacute Large Artery Ischemic Stroke
|
Phase 3 | |
| Terminated |
NCT03396419 -
IMPACT- 24col Collateral Blood Flow Assessment Following SPG Stimulation in Acute Ischemic Stroke (ImpACT-24B Sub-Study)
|
||
| Recruiting |
NCT05065216 -
Treatment of Acute Ischemic Stroke (ReMEDy2 Trial)
|
Phase 2/Phase 3 | |
| Recruiting |
NCT04897334 -
Transcranial Direct Current Stimulation and Rehabilitation to Ameliorate Impairments in Neurocognition After Stroke
|
N/A | |
| Not yet recruiting |
NCT06032819 -
Differentiating Between Brain Hemorrhage and Contrast
|
||
| Not yet recruiting |
NCT06026696 -
Cohort of Neurovascular Diseases Treated in the Acute Phase and Followed at Lariboisière
|
||
| Recruiting |
NCT02910180 -
Genetic, Metabolic, and Growth Factor Repository for Cerebrovascular Disorders
|
||
| Withdrawn |
NCT01866189 -
Identification of Hypoxic Brain Tissues by F-MISO PET in Acute Ischemic Stroke
|
N/A | |
| Completed |
NCT02922452 -
A Study to Evaluate the Effect of Diltiazem on the Pharmacokinetics (PK) of BMS-986141 in Healthy Subjects
|
Phase 1 | |
| Completed |
NCT03554642 -
Walkbot Robotic Training for Improvement in Gait
|
Phase 3 | |
| Recruiting |
NCT03041753 -
Reperfusion Injury After Stroke Study
|
N/A | |
| Completed |
NCT02549846 -
AdminiStration of Statin On Acute Ischemic stRoke patienT Trial
|
Phase 4 | |
| Completed |
NCT01678534 -
Reparative Therapy in Acute Ischemic Stroke With Allogenic Mesenchymal Stem Cells From Adipose Tissue, Safety Assessment, a Randomised, Double Blind Placebo Controlled Single Center Pilot Clinical Trial
|
Phase 2 | |
| Completed |
NCT02610803 -
Paroxysmal Atrial Fibrillation in Patients With Acute Ischemic Stroke
|
N/A | |
| Completed |
NCT01983644 -
RECO Flow Restoration Device Versus Solitaire FR With the Intention for Thrombectomy Study
|
N/A |